Literature DB >> 16034479

Cross-talk between adenosine and opioid receptors.

Jason N Peart1, Garrett J Gross.   

Abstract

Opioid and adenosine receptors are implicated in numerous physiological and pathophysiological states. Moreover, both G-protein-coupled receptor families have been demonstrated to provide significant protection against ischemic injury in the myocardium and central nervous system (CNS). Much recent data report a tight interaction between these two receptor families, from alterations in receptor sensitivity to release of endogenous adenosine in the presence of morphine. Indeed, it appears that the cardioprotective effects of adenosine can be abolished by opioid receptor antagonists and vice-versa. This review aims to highlight some of the research, derived from both the CNS and myocardium, supporting this interesting interaction. 2005 Prous Science. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034479     DOI: 10.1358/dnp.2005.18.4.908657

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  3 in total

1.  Adenosine A(1) receptor agonist N(6)-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signaling.

Authors:  Yun Cheng; Yi-min Tao; Jian-feng Sun; Yu-hua Wang; Xue-jun Xu; Jie Chen; Zhi-qiang Chi; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

Review 2.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

3.  Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts.

Authors:  Tina C Wan; Dilip K Tosh; Lili Du; Elizabeth T Gizewski; Kenneth A Jacobson; John A Auchampach
Journal:  BMC Pharmacol       Date:  2011-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.